Q&A with Verici Dx CEO, Sara Barrington
Episode 879, Sep 07, 2022, 09:40 AM
Watch the video HERE
Developing world beating medical science goes hand-in-hand with
Verici DX #VRCI. A next generation, immuno-diagnostics firm, specialising in kidney transplants.
In this interview, CEO Sara Barrington takes Vox Markets through today’s upbeat interims, including the:
Positive trial results of the company’s 2 lead tests Tuteva (start) and Clarava (08:10).
Broader validation of its innovative RNA technology platform. 13:05
Theoretical size of the addressable market. 16:55
Next steps for 3rd Protega diagnostic. 19:55
Significance of Illumina collaboration. 20;55
Cash runway ahead. 25:15
Future newsflow. 26:45
Developing world beating medical science goes hand-in-hand with
Verici DX #VRCI. A next generation, immuno-diagnostics firm, specialising in kidney transplants.
In this interview, CEO Sara Barrington takes Vox Markets through today’s upbeat interims, including the:
Positive trial results of the company’s 2 lead tests Tuteva (start) and Clarava (08:10).
Broader validation of its innovative RNA technology platform. 13:05
Theoretical size of the addressable market. 16:55
Next steps for 3rd Protega diagnostic. 19:55
Significance of Illumina collaboration. 20;55
Cash runway ahead. 25:15
Future newsflow. 26:45